ELV241018C520000
- 0.03
- +0.02+200.00%
Elevance Health Newsroom
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $520 to $622
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), AbbVie (ABBV) and Elevance Health (ELV)
Elevance Health Price Target Cut to $478.00/Share From $585.00 by RBC Capital
A Quick Look at Today's Ratings for Elevance Health(ELV.US), With a Forecast Between $520 to $625
Elevance Health Is Maintained at Overweight by Cantor Fitzgerald
Cantor Fitzgerald Maintains Overweight on Elevance Health, Lowers Price Target to $485
Elevance Health Analyst Ratings
Truist Cuts Price Target on Elevance Health to $520 From $620, Keeps Buy Rating
Analysts Are Bullish on Top Healthcare Stocks: Tenaya Therapeutics (TNYA), Elevance Health (ELV)
Barclays Sticks to Its Buy Rating for Elevance Health (ELV)
Stephens Cuts Elevance Health's Price Target to $520 From $615
Optimistic Buy Rating for Elevance Health Despite Earnings Miss, Driven by Strong Segment Performance and Future Potential
Baird Maintains Elevance Health(ELV.US) With Buy Rating, Cuts Target Price to $625
Elevance Health: Buy Rating Affirmed Amid Attractive Valuation and Positive Long-Term Outlook
TD Cowen Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $589
Elevance Health (ELV) Gets a Buy From TD Cowen
Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Maintains Target Price $622
Elevance Health Is Maintained at Overweight by Barclays
Elevance Health Analyst Ratings
Barclays Maintains Elevance Health(ELV.US) With Buy Rating, Raises Target Price to $622